Neutra Corp. (NTRR)

USD 0.0

(0.0%)

Total Debt Summary of Neutra Corp.

  • Neutra Corp.'s latest annual total debt in 2024 was 54.15 Thousand USD , down 0.0% from previous year.
  • Neutra Corp.'s latest quarterly total debt in 2024 FY was 54.15 Thousand USD , down 0.0% from previous quarter.
  • Neutra Corp. reported annual total debt of 54.15 Thousand USD in 2023, down -77.41% from previous year.
  • Neutra Corp. reported annual total debt of 239.71 Thousand USD in 2022, down 0.0% from previous year.
  • Neutra Corp. reported quarterly total debt of 54.15 Thousand USD for 2024 FY, down 0.0% from previous quarter.
  • Neutra Corp. reported quarterly total debt of 54.15 Thousand USD for 2024 Q2, down 0.0% from previous quarter.

Annual Total Debt Chart of Neutra Corp. (2024 - 2011)

Historical Annual Total Debt of Neutra Corp. (2024 - 2011)

Year Total Debt Total Debt Growth
2024 54.15 Thousand USD 0.0%
2023 54.15 Thousand USD -77.41%
2022 239.71 Thousand USD 0.0%
2021 239.71 Thousand USD -23.26%
2020 312.37 Thousand USD -46.99%
2019 589.25 Thousand USD 259.53%
2018 163.89 Thousand USD 93.63%
2017 84.64 Thousand USD 382.3%
2016 17.55 Thousand USD -66.44%
2015 52.29 Thousand USD -70.6%
2014 177.88 Thousand USD 1775.64%
2013 9484.00 USD -79.91%
2012 47.2 Thousand USD 0.0%
2011 - USD 0.0%

Peer Total Debt Comparison of Neutra Corp.

Name Total Debt Total Debt Difference
Eiger BioPharmaceuticals, Inc. 41.2 Million USD 99.869%
Nanobac Pharmaceuticals, Incorporated 4.12 Million USD 98.686%
SQZ Biotechnologies Company 27.47 Million USD 99.803%
Evofem Biosciences, Inc. 43.37 Million USD 99.875%
Santhera Pharmaceuticals Holding AG 29.76 Million USD 99.818%
Mesoblast Limited 118.7 Million USD 99.954%
Propanc Biopharma, Inc. 948.27 Thousand USD 94.289%
Genus plc 233.1 Million USD 99.977%
VioQuest Pharmaceuticals, Inc. 2.93 Million USD 98.152%
CNBX Pharmaceuticals Inc. 1.34 Million USD 95.969%
Marizyme, Inc. 18.71 Million USD 99.711%
ContraFect Corporation 2.88 Million USD 98.12%
Nymox Pharmaceutical Corporation 750 Thousand USD 92.779%
PsyBio Therapeutics Corp. 135.48 Thousand USD 60.029%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.44 Million USD 96.256%
Intellipharmaceutics International Inc. 2.32 Million USD 97.672%
AXIM Biotechnologies, Inc. 5.65 Million USD 99.043%
MultiCell Technologies, Inc. 202.58 USD -26633.142%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 57.48 Million USD 99.906%
EV Biologics, Inc. 1.49 Million USD 96.377%
Q BioMed Inc. 4.1 Million USD 98.682%
Emmaus Life Sciences, Inc. 33.1 Million USD 99.836%
Neon Bloom, Inc. 630.07 Thousand USD 91.405%
Mosaic ImmunoEngineering Inc. 1.22 Million USD 95.591%
Biomind Labs Inc. 735.54 Thousand USD 92.637%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 171.54 Million USD 99.968%
Oncotelic Therapeutics, Inc. 12.99 Million USD 99.583%
Skye Bioscience, Inc. 4.61 Million USD 98.827%
Therapeutic Solutions International, Inc. 888.06 Thousand USD 93.902%
THC Farmaceuticals, Inc. 141.51 Thousand USD 61.732%
Arch Therapeutics, Inc. 5.87 Million USD 99.078%
IMV Inc. 28.88 Million USD 99.813%
Acro Biomedical Co., Ltd. 25.71 Thousand USD -110.568%
Curative Biotechnology, Inc. 2.25 Million USD 97.602%
GB Sciences, Inc. 1.75 Million USD 96.922%
Alpha Cognition Inc. 1.22 Million USD 95.562%
HST Global, Inc. 98.31 Thousand USD 44.918%
CSL Limited 12.18 Billion USD 100.0%
Halberd Corporation 150 Thousand USD 63.896%
Enzolytics Inc. 996.33 Thousand USD 94.564%
Resverlogix Corp. 6.49 Million USD 99.166%
Affymax, Inc. - USD -Infinity%
SYBLEU INC 477.5 Thousand USD 88.658%
Nuo Therapeutics, Inc. 255.59 Thousand USD 78.812%
argenx SE 20 Million USD 99.729%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 45.56 Million USD 99.881%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. 2.7 Million USD 98.001%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
Zenith Capital Corp. 10.22 Thousand USD -429.643%
Genscript Biotech Corporation 417.73 Million USD 99.987%
Ember Therapeutics, Inc. 200.61 Thousand USD 73.005%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 2.39 Million USD 97.741%
WPD Pharmaceuticals Inc. 229.29 Thousand USD 76.381%
American Oriental Bioengineering, Inc. 67.64 Million USD 99.92%
Provectus Biopharmaceuticals, Inc. 3.02 Million USD 98.21%
Adynxx, Inc. - USD -Infinity%
Helix BioMedix, Inc. - USD -Infinity%
GlobeStar Therapeutics Corporation 359.71 Thousand USD 84.945%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 20.32 Million USD 99.734%
Cotinga Pharmaceuticals Inc. 148.65 Thousand USD 63.569%
BioStem Technologies, Inc. 4.71 Million USD 98.851%
ONE Bio Corp. 19.71 Million USD 99.725%
Reve Technologies, Inc. 250.18 Thousand USD 78.353%
Burzynski Research Institute, Inc. - USD -Infinity%
Wesana Health Holdings Inc. 248.72 Thousand USD 78.226%
Agentix Corp. 50 Thousand USD -8.312%
LadRx Corporation 33.6 Thousand USD -61.15%
Cell Source, Inc. 9.25 Million USD 99.415%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 756.2 Thousand USD 92.838%
Regen BioPharma, Inc. 756.2 Thousand USD 92.838%
NovAccess Global Inc. 2.19 Million USD 97.538%
Endonovo Therapeutics, Inc. 7.07 Million USD 99.234%
Itoco Inc. 228.37 Thousand USD 76.287%
Rasna Therapeutics, Inc. 210.97 Thousand USD 74.331%
Pathfinder Cell Therapy, Inc. 4.98 Million USD 98.913%
Kadimastem Ltd 891.22 Thousand USD 93.923%
Oncology Pharma Inc. - USD -Infinity%
Institute of Biomedical Research Corp. 401.84 Thousand USD 86.523%
CytoDyn Inc. 30.07 Million USD 99.82%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
Mobile Lads Corp. 484.28 Thousand USD 88.817%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. 351.84 Thousand USD 84.608%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 99.307%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. 122.5 Thousand USD 55.791%
Rebus Holdings, Inc. 310 Thousand USD 82.53%
ImmunoCellular Therapeutics, Ltd. 4.73 Million USD 98.856%
International Stem Cell Corporation 4.17 Million USD 98.704%
Bioxytran, Inc. 1.92 Million USD 97.187%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. 62.41 Thousand USD 13.23%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. 2.18 Million USD 97.517%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.31 Million USD 99.349%
Adhera Therapeutics, Inc. 8.58 Million USD 99.369%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. 1.55 Million USD 96.518%
Innovation Pharmaceuticals Inc. 268 Thousand USD 79.793%
Windtree Therapeutics, Inc. 1.83 Million USD 97.041%
PureTech Health plc 25.51 Million USD 99.788%
Coeptis Therapeutics, Inc. 1.22 Million USD 95.576%
IXICO plc 472.02 Thousand USD 88.527%
IntelGenx Technologies Corp. 15.5 Million USD 99.651%
Gelesis Holdings, Inc. 62.26 Million USD 99.913%
CSL Limited 12.18 Billion USD 100.0%
Cellectis S.A. 92.77 Million USD 99.942%